INTRODUCTION
============

The functional diversity of microtubules is achieved by various posttranslational modifications of tubulin, including acetylation, tyrosination, glutamylation, glycylation, and phosphorylation ([@B12]; [@B44]). Glutamylation, the most abundant tubulin modification ([@B2]), adds glutamates to glutamate residues in the carboxyl termini of α- and β-tubulin. In particular, axonemal microtubules undergo polyglutamylation, in which as many as 21 glutamates are added to the tubulin ([@B38]). This successive addition of glutamates is performed by the members of tubulin tyrosine ligase-like (TTLL) protein family ([@B12]). We previously isolated a *Chlamydomonas* mutant, *tpg1*, that lacks TTLL9 and thereby has reduced level of tubulin polyglutamylation ([@B20]). The phenotype of *tpg1* mutant indicates that tubulin polyglutamylation is involved in the regulation of flagellar motility and stability of axonemal microtubules ([@B20]; [@B19]). Furthermore, previous studies suggested that tubulin polyglutamylation regulates flagellar motility by controlling specific axonemal dynein and the nexin--dynein regulatory complex (N-DRC; [@B18]; [@B1]). Although conventional immuno--electron microscopy showed that polyglutamylated tubulins are located on the B-tubule surface of the outer doublet microtubule (DMT; [@B21]; [@B41]; [@B20]), it is necessary to conduct a three-dimensional (3D) structural analysis to investigate the relationship between the polyglutamylated tubulins and the axonemal dyneins or the N-DRC.

The N-DRC is a microtubule-cross-bridging structure that maintains the circular arrangement of the DMT in the axoneme ([@B9]). Mutations in N-DRC components result in motility defects, which cause primary ciliary dyskinesia ([@B10]; [@B7]; [@B3]; [@B43]). Our previous study suggested that the N-DRC loosely attaches to the DMT, so that it allows DMT sliding during the flagellar beating ([@B33]). However, it remains unknown how the N-DRC enables DMT cross-bridging and DMT sliding simultaneously. In this study, we identified the 3D localization of the polyglutamylated tubulin within the axoneme and functionally characterized the interaction between the N-DRC and the polyglutamylated tubulin. Our results suggest an electrostatic force--dependent mechanism of motility regulation in eukaryotic flagella.

RESULTS AND DISCUSSION
======================

Labeling polyglutamylated tubulins in intact axonemes
-----------------------------------------------------

We labeled the polyglutamylated axonemal tubulins in *Chlamydomonas* flagella by raising polyclonal antibodies against polyglutamate peptide in two rabbits ([@B39]). The resulting antibodies, polyE\#1 and \#2, efficiently recognized the denatured axonemal tubulins in immunoblotting ([Figure 1, A and B](#F1){ref-type="fig"}). In the *tpg1* mutant, we found that axonemal tubulins could not be labeled with our new polyE antibodies ([Figure 1A and B](#F1){ref-type="fig"}). The polyE\#2 antibody showed better specificity than \#1, and thus we designated it simply as "polyE2" and used it exclusively in further experiments.

![The polyE antibody labeling of the axonemes. (A, B) Immunoblots of denatured axonemal tubulins. (A) Our new polyE antibody (\#1 and \#2)--labeled polyglutamylated tubulins compared with commercially available polyE antibody ([@B39]). (B) Probing with the polyE antibodies showed that the polyglutamylation levels were unaffected by deficiency in ODA (*oda1*), IDA (*ida1*, *ida4*, and *ida5*), and N-DRC (*pf2*, *pf3*, *pf2pf3*, and *pf2ida6*). (C, D) PolyE2 labeling of the intact axonemes. Axonemes were incubated with the biotinylated Fab fragments of the polyE2 antibody. (C) Labeled axonemes were boiled and separated by electrophoresis. Bound biotinylated Fab fragments were detected using horseradish peroxidase--conjugated streptavidin. Blots with anti-PACRG antibody are shown as a loading control. (D) PolyE2-labeled axonemes were stained with streptavidin--Alexa 546. See Supplemental Figure S1 for fluorescence images of axonemes of other strains.](2260fig1){#F1}

Next we examined whether polyE2 could label native tubulins within intact axonemes. The immunoglobulin G molecule is too large to penetrate into the axoneme ([@B31]; [@B29]), so we digested the polyE2 antibody with papain to generate Fab fragments. We incubated the axonemes with biotinylated Fab fragments of polyE2 antibody and observed binding using both immunoblotting ([Figure 1C](#F1){ref-type="fig"}) and fluorescence microscopy ([Figure 1D](#F1){ref-type="fig"}). In contrast, polyE2 Fab fragments only faintly labeled intact and native wild-type axonemes ([Figure 1, C and D](#F1){ref-type="fig"}). Because polyE antibody can bind to frayed and aldehyde-fixed axonemes ([@B20]), we speculated that polyglutamylated tubulins were masked by axonemal structures, such as outer dynein arms (ODAs), inner dynein arms (IDAs), or the N-DRC. Contrary to our expectation, however, polyE2 Fab fragments did not efficiently label ODA-missing (*oda1*) and IDA-deficient (*ida1*, *ida4*, and *ida5*) axonemes ([Figure 1C](#F1){ref-type="fig"}, Supplemental Figure S1, and Supplemental Table S1; [@B14]; [@B42]), whereas N-DRC--deficient (*pf2*, *pf3*, and *ida6*) axonemes were labeled relatively well compared with others, but the staining patterns were sporadic ([Figure 1C](#F1){ref-type="fig"} and Supplemental Figure S1). Biochemically, the N-DRC in *pf2* axoneme retains DRC1 and DRC2, whereas DRC3 and DRC4 are missing ([@B23]), suggesting that the remaining components of the N-DRC in the *pf2* axoneme still mask the polyglutamylated tubulins ([@B33]). Therefore we generated the double mutant *pf2pf3*, which is deficient in all of the major components (DRC1--7) of the N-DRC ([@B23]). Surprisingly, we found that polyE2 Fab fragments efficiently labeled the *pf2pf3* axonemes ([Figure 1, C and D](#F1){ref-type="fig"}). Similarly, *pf2ida6* axonemes were also efficiently labeled with the polyE2 Fab fragments. However, Fab binding was drastically reduced in axonemes carrying the *tpg1* background (*tpg1pf2pf3* and *tpg1pf2ida6*; [Figure 1, C and D](#F1){ref-type="fig"}). These results suggest that polyglutamylated tubulins are masked by the N-DRC.

Three-dimensional localization of polyglutamylated tubulins
-----------------------------------------------------------

To identify the 3D localization of the polyglutamylated tubulins, we labeled *pf2pf3* axonemes with biotinylated polyE2 Fab fragments and then amplified the physical size of the labels using streptavidin and biotinylated cytochrome *c* ([@B34]; [@B29]). Cryo--electron tomography and subtomogram averaging of the labeled DMTs revealed that the label densities were located on the B-tubule surface, which are masked by the N-DRC in wild-type axonemes ([Figure 2, A and B](#F2){ref-type="fig"}, and Supplemental Figure S2A). In contrast, *tpg1pf2pf3* axonemes did not show significant label densities.

![Three-dimensional localization of polyglutamylated tubulin. (A) Three-dimensional structure of the N-DRC in the *Chlamydomonas* axoneme. Right, tip-to-base view of the 9 + 2 structure of the axoneme. Middle, cross-sectional view of the DMT. The N-DRC is shown in yellow. Left, internal slab view of the boxed region. The N-DRC contacts the B-tubule at the distal lobe. (B) DMT structures of unlabeled *pf2pf3*, polyE2-labeled *pf2pf3*, and polyE2-labeled *tpg1pf2pf3* axonemes. Internal slab (left and middle) and top (right) views. The label densities are in red. A *t*-value map (*t*-map, red) was calculated by comparing the labeled and unlabeled *pf2pf3* structures. The wild-type DMT structure is superimposed on the *t*-value map as a transparent mesh isosurface. The N-DRC is shown in yellow. (C) Positions of the amino termini of DRC2 (green) and DRC4 (blue) as reported previously ([@B33]).](2260fig2){#F2}

[@B1] reported that the motility defect in *tpg1* cells is related to the distal lobe of the N-DRC ([Figure 2A](#F2){ref-type="fig"}). In our previous report ([@B33]), we also showed that the distal lobe of the N-DRC loosely binds to the B-tubule and allows sliding of the DMT. In particular, the amino terminus of DRC4 locates in close proximity to the B-tubule surface ([Figure 2C](#F2){ref-type="fig"}, blue; [@B33]; [@B40]). The amino terminus of DRC2 also locates in the distal lobe of the N-DRC, but its position is slightly away from the B-tubule surface ([Figure 2C](#F2){ref-type="fig"}, green). Because the amino acid sequence of the amino-terminal domain of DRC4 is rich in lysine residues ([@B37]), we hypothesized that the N-DRC interacts with the DMT via electrostatically driven "cross-bridges" between the positively charged amino terminus of the DRC4 and the negatively charged polyglutamylated tubulin ([Figure 3A](#F3){ref-type="fig"}).

![Effects of replacement and addition of Lys residues on flagellar motility. (A) Schematic diagram of the DMT and the N-DRC, showing the possible electrostatic interaction between the polyglutamate chain (circled E) extending from the B-tubule and the polylysine chain (circled K) on the DRC4. The coiled-coil complex of DRC2 and DRC4 is indicated by orange wavy lines. (B, C) Swimming velocities of DRC4 and DRC2 mutants. Residue replacements and additions are shown next to the strain names. Asterisks indicate statistically significant differences (*p* \< 0.01). The *p* values were calculated using Student's *t* test. Means ± SEM for the mean swimming velocities were calculated from 20 cells. (B) Lys residues on DRC4 and DRC2 were replaced with either Glu or Gln. (C) A total of 6 or 23 residues of Lys and Arg residues were inserted after the Pro-3 of DRC4. (D) Schematic diagrams of the interaction between DRC4 and the B-tubule. In *tpg1*, the interaction between the poly-Lys on DRC4 and the B-tubule is abolished. In *DRC4 pK23*, the hyper-poly-Lys peptide on DRC4 forms an excessively strong cross-bridge with polyglutamylated tubulin on the B-tubule.](2260fig3){#F3}

Net charge of DRC4 affects flagellar motility
---------------------------------------------

To test our "electrostatic interaction hypothesis," we changed the amino acid composition of the DRC4 amino terminus ([Figure 3, B and C](#F3){ref-type="fig"}, and Supplemental Figure S3A). First, we replaced the lysine residues with glutamate or glutamine and expressed the modified DRC4 in *pf2* cells. The transformed cells showed a charge inversion--dependent decrease in swimming velocity ([Figure 3B](#F3){ref-type="fig"}), indicating that the interaction between positively charged DRC4 and polyglutamylated tubulin is required for normal flagellar motility. However, replacement of the lysine residues in DRC2 with glutamate had little effect on the swimming velocity.

To modify the electrostatic cross-bridge, we next added lysine and arginine residues to the amino terminus of DRC4 and expressed the modified protein in *pf2* and *tpg1pf2* cells*.* Of interest, the addition of 23 positively charged residues to DRC4 (*DRC4pK23*) caused a decrease in the swimming velocity, suggesting that excessively strong electrostatic interaction between the N-DRC and the B-tubule impedes microtubule sliding ([Figure 3D](#F3){ref-type="fig"}). This possibility is supported by the observation that the *tpg1 DRC4pK23* cells swam faster than *DRC4pK23* cells. Finally, we expressed this hyperpositively charged DRC4 in *pf2ida6* and *tpg1pf2ida6* cells ([Figure 4A](#F4){ref-type="fig"}). Based on the previous reports ([@B23]; [@B33]), the N-DRC in *ida6* (DRC2-deficient) axonemes is expected to retain the microtubule-cross-bridging capacity via the remaining DRC4. Expression of DRC4pK23 protein partially rescued the motility defect of *ida6* cells, suggesting that the augmented positive charges on DRC4 could partially complement the weakened interaction between the defective N-DRC and the B-tubule in *ida6* ([Figure 4B](#F4){ref-type="fig"}). In accordance with this model, expression of DRC4pK23 protein did not restore the motility of *tpg1pf2ida6* cells.

![Effect of poly-Lys addition on the motility defect of *ida6*. (A) The motility defect in *ida6* (DRC2-deficient) cells was partially rescued by the addition of hyper-poly-Lys on DRC4. No restoration of the flagellar motility was observed in *tpg1ida6*. Asterisks indicate statistically significant differences (*p* \< 0.01). The *p* values were calculated using Student's *t* test. Means ± SEM for the mean swimming velocities were calculated from 20 cells. See Supplemental Figure S3B for the swimming velocities of other strains. (B) Schematic diagrams of the cross-bridge between the hyper-poly-Lys peptide on DRC4 and the polyglutamate chain of the B-tubule. In *ida6*, the absence of DRC2 causes structural defects in the N-DRC and weakens its interaction with the B-tubule. The hyper-poly-Lys peptide on DRC4 reinforces the interaction with the polyglutamylated tubulins to partially restore N-DRC function.](2260fig4){#F4}

Relationship between IDA *e* and polyglutamylated tubulin
---------------------------------------------------------

We previously showed ([@B18]) that there is a genetic interaction between IDA *e* and tubulin polyglutamylation, based on the observation that *tpg1ida4* cells were essentially nonmotile, whereas *tpg1ida5* cells showed clear motility, although slightly slower than that of *ida5* cells. Both *ida4* and *ida5* mutants lack the IDA subspecies *a*, *c*, and *d*, but only *ida5* lacks IDA *e* ([@B15]; [@B13]; [@B16]). These results suggested that IDA *e* can interact with the polyglutamylated tubulins and that IDA *e* has a negative effect on the flagellar motility in the absence of tubulin polyglutamylation. The present results revealed that the polyglutamylated tubulins are located on the protofilament facing the N-DRC ([Figure 2](#F2){ref-type="fig"}). [@B22] reported that the microtubule-binding domains of IDAs and the distal lobe of the N-DRC attach to different protofilaments of the B-tubule. Thus it is unlikely that IDA *e* interacts with the polyglutamylated tubulins on the B-tubule. The difference in flagellar motility between *tpg1ida4* and *tpg1ida5* cells may result from the possible functional interaction between the N-DRC and IDA *e*. N-DRC-defective mutants such as *pf2*, *pf3*, and *ida6* lack or have reduced amounts of IDA *e* ([@B15]; [@B5]; [@B32]). In contrast, IDA *e*--deficient *ida5* has an intact N-DRC ([@B6]), suggesting that assembly of IDA *e* structurally depends on the N-DRC. We previously showed that mechanical signals are transmitted from the central pair apparatus to the ODAs through the radial spokes ([@B34]). These mechanical signals are likely to travel along the outer--inner dynein linker between the N-DRC and the ODA ([@B32], [@B33], [@B30]). Considering the structural interaction between the N-DRC and the IDA *e*, it is possible that the N-DRC regulates the IDA *e* by mechanosignal inputs, which can be altered in the absence of tubulin polyglutamylation. Therefore we reasoned that the difference in flagellar motility between *tpg1ida4* and *tpg1ida5* mutants may result from an indirect effect of the *tpg1* background on the IDA *e* through the aberrant regulatory inputs from the N-DRC. Testing this hypothesis will require functional analyses of the IDA *e* using a mutant lacking only IDA *e*. Similarly, the N-DRC is structurally connected to IDA *g* through DRC3 ([@B4]). It is of interest to investigate whether the activity of IDA *g* is also affected by tubulin polyglutamylation.

Determinants of the polyglutamylation sites
-------------------------------------------

In summary, our results suggest that the positively charged surface of the distal lobe of the N-DRC interacts with the negatively charged surface of the B-tubule. The strength of the electrostatic force between the N-DRC and the B-tubule appears to be tightly regulated because both an increase and a reduction of the positive charge on the N-DRC reduced flagellar motility. Of interest, the function of structurally defective N-DRC was partially restored by increasing the positive charge on the N-DRC, suggesting that the N-DRC regulates flagellar motility via a chemically simple (and artificially manipulatable) mechanism.

Our results show that the polyglutamylation sites localize on the interface between the N-DRC and the B-tubule. However, there remains a possibility that the averaged subtomogram fails to visualize other polyglutamylated tubulins, whose localizations do not conform to the 96-nm repeat of the DMT or are structurally inaccessible to polyE2 Fab fragments. To address this question, we roughly estimate the amount of polyglutamylated tubulin based on the previous biochemical data. Two-dimensional gel electrophoresis of wild-type and *tpg1* axonemes shows that ∼1.5% of total axonemal tubulin is polyglutamylated ([Figure 1D](#F1){ref-type="fig"} of [@B20]). This estimation agrees with the mass spectrometric result on sea urchin sperm axonemes that only a trace amount of tubulin is polyglutamylated ([@B26]). The label density of polyE2 Fab on *pf2pf3* axoneme spans ∼15 nm ([Figure 2B](#F2){ref-type="fig"}), corresponding roughly to two tubulin dimers. Given that there are 276 tubulin dimers in one 96-nm repeat of the DMT (96/8 nm × 23 protofilaments; [@B27]; [@B24]), the labeled tubulins in our electron density map represent a good amount but not all of the polyglutamylated tubulins in the axoneme. The localization and function of these unvisualized tubulins remain to be investigated.

Another remaining question is how TTLL9 glutamylates specifically the N-DRC--facing part of the B-tubule. One possibility is that the N-DRC recruits TTLL9 through direct binding. However, the unchanged polyglutamylation levels in *pf2*, *pf3*, *pf2pf3*, and *pf2ida6* mutants ([Figure 1B](#F1){ref-type="fig"}) suggest that the N-DRC itself is dispensable for the activity and regulation of TTLL9. It has been reported that TTLL9 forms a complex with an adaptor protein FAP234, which is essential for the axonemal localization of TTLL9 ([@B19]). It is possible that FAP234 is also involved in the localized activation of TTLL9. Investigation of the molecular mechanisms for the spatial regulation of polyglutamylation will require identifying the localizations of the TTLL9--FAP234 complex and other glutamylases and deglutamylases.

MATERIALS AND METHODS
=====================

Strains and reagents
--------------------

*Chlamydomonas reinhardtii* wild-type strain CC-125 cells were grown in Tris-acetate-phosphate (TAP) medium. To screen transformants, cells were grown on TAP agar supplemented with hygromycin B (20 μg/ml; Nacalai Tesque, Kyoto, Japan). The *C. reinhardtii* strains used in this study are listed in Supplemental Table S1. Expression plasmids for DRC4 were as described previously ([@B33]). Residue addition and replacement were carried out using an In-Fusion HD Cloning Kit (Clontech, Palo Alto, CA). B512 mouse monoclonal anti--α-tubulin antibody and polyE anti-polyglutamate antibody were purchased from Sigma-Aldrich (St. Louis, MO) and Adipogen Life Sciences (San Diego, CA), respectively. Anti-DRC2 ([@B32]), DRC4 ([@B32]), IC1 ([@B30]), and PACRG ([@B11]) antibodies were described previously.

Preparation of axonemes
-----------------------

*Chlamydomonas* cells were deflagellated with dibucaine-HCl (Wako Pure Chemical Industries, Tokyo, Japan), and axonemes were collected by centrifugation ([@B36]). Flagella were demembranated with 1% Nonidet P-40 in HMDENa buffer or HMDEK buffer composed of 30 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)--NaOH pH 7.2, 5 mM MgCl~2~, 1 mM dithiothreitol, 1 mM ethylene glycol tetraacetic acid, 50 mM NaCl (HMDENa) or 50 mM CH~3~COOK (HMDEK), and 1× protease inhibitor cocktail (Nacalai Tesque).

Generation of biotinylated Fab fragments of polyE2 antibody
-----------------------------------------------------------

Anti-polyglutamate polyclonal rabbit antisera (polyE\#1 and \#2) were raised commercially (Hokkaido System Science, Sapporo, Japan; Evebio Science, Wakayama, Japan) against Cys(Glu)~9~ peptide coupled to keyhole limpet hemocyanin ([@B39]). The new polyE\#2 antibody (referred to as polyE2) was purified by ammonium sulfate precipitation ([@B8]) and digested at 37°C for 6 h with papain (Nacalai Tesque, Kyoto, Japan) after dialysis against digestion buffer (20 mM HEPES-NaOH, pH 7.0, 10 mM EDTA, 20 mM cysteine HCl). Fab fragments were then cross-linked with a 40-fold molar excess of biotin-OSu (Dojindo Molecular Technologies, Kumamoto, Japan). Unreacted biotin was quenched with 0.1 M glycine and removed by three rounds of desalting using PD Mini-Trap G-25 columns (GE Healthcare, Pittsburgh, PA).

Electrophoresis and immunoblotting
----------------------------------

Axonemal proteins were resolved by SDS--PAGE on 5--15% polyacrylamide gradient gels (Nacalai Tesque) and then blotted onto polyvinylidene difluoride membranes. Blots were probed with streptavidin conjugated with horseradish peroxidase (Thermo Scientific, Rockford, IL) or the indicated primary antibodies.

Fab labeling and fluorescence microscopy detection of axonemes
--------------------------------------------------------------

For antibody labeling, demembranated axonemes were blocked with 1 mg/ml bovine serum albumin (BSA) in HMDENa buffer for 1 h at 4°C and then incubated with 10 μg/ml biotinylated Fab fragments of the polyE2 antibody for 1 h at 4°C. Labeled axonemes were washed twice with HMDENa buffer and then attached to glass slides or boiled for the electrophoresis. For fluorescence staining using streptavidin, axonemes and glass slides were blocked with 1 mg/ml BSA in HMDENa buffer and then incubated with 1 μg/ml Alexa Fluor 546--conjugated streptavidin (Invitrogen, Carlsbad, CA) for 1 min. Axonemes were then washed three times with HMDENa buffer and observed using a fluorescence microscope (BX53; Olympus, Tokyo, Japan). Images were recorded using a charge-coupled device camera (ORCA-Flash4.0 V3; Hamamatsu Photonics, Hamamatsu, Japan).

Sample preparation for cryo--electron tomography
------------------------------------------------

Streptavidin--cytochrome *c* labeling of polyE2 Fab-labeled axonemes was carried out as described previously ([@B34]) with minor modifications. Demembranated axonemes were incubated with 0.05 mg/ml biotinylated Fab fragments for 1 h at 4°C in HMDENa buffer in the presence of 1 mg/ml BSA. Axonemes were then washed with HMDENa buffer and incubated with 0.05 mg/ml streptavidin for 15 min at 4°C. Next axonemes were washed and again incubated with 0.05 mg/ml biotinylated cytochrome *c*. This sequence was repeated, so that the biotinylated Fab fragments were labeled with three rounds of streptavidin and two rounds of cytochrome *c*. Labeled or unlabeled axonemes were resuspended in HMDEK buffer at a concentration of 0.02 mg/ml and mixed with cationic 15-nm colloidal gold (BBI Solutions, Cardiff, United Kingdom). Homemade holey carbon grids were glow discharged for 20 s. Suspended axonemes plus colloidal gold (5 μl) was loaded onto the grids and plunge-frozen in liquid ethane at −180°C with a Vitrobot Mark IV automated plunge-freezing device (FEI, Hillsboro, OR).

Image acquisition
-----------------

Grids were transferred to a JEM-3100FEF transmission electron microscope (JEOL, Tokyo, Japan) with a Gatan 914 high-tilt liquid nitrogen cryotransfer holder (Gatan, Pleasanton, CA). Tilt series images were recorded at −180°C using a TemCam-F416 complementary metal-oxide semiconductor camera (TVIPS, Gauting, Germany), and automated acquisition was performed using the EM-TOOLs program (TVIPS). The angular range of the tilt series was from --60 to 60° at 2.0° increments. The total electron dose was limited to ∼100 e^--^/Å^2^. Images were recorded at 300 keV with 6- to 9-μm defocus at a magnification of 22,300× and a pixel size of 7 Å. An in-column omega energy filter was used to enhance image contrast in the zero-loss mode with a slit width of 20 eV.

Image processing
----------------

Image processing for subtomogram averaging of DMT structures was carried out as described previously ([@B31]; [@B34]). Tilt series images were aligned and backprojected to reconstruct 3D tomograms using the IMOD software package ([@B17]). Tomograms of intact axonemes with a high signal-to-noise ratio were selected and used for subtomogram averaging of the 96-nm repeats of DMTs. Alignment and averaging of subtomograms were conducted using custom Ruby-Helix scripts ([@B25]) and the PEET software suite ([@B28]). The number of DMT subtomograms averaged was as follows: 766 for wild type, 963 for *pf2pf3*, 846 for *pf2pf3* plus polyE2, and 952 for *tpg1pf2pf3* plus polyE2. The effective resolutions determined by Fourier shell correlation with a cutoff value of 0.5 were ∼5.0 nm (Supplemental Figure S2B). Surface renderings were generated using UCSF Chimera ([@B35]). The electron microscopic maps of averaged DMTs are available at the EM Data Bank ([www.emdatabank.org](http://www.emdatabank.org)) under the accession numbers EMD-6753--6756.

Statistical analysis
--------------------

We identified statistically significant differences by applying Student's *t* test to compare unlabeled *pf2pf3* and polyE2-labeled *pf2pf3* axonemes as described previously ([@B31]; [@B34]). First, unlabeled and labeled subtomograms were randomly divided into three data sets. Subtomograms for each data set were aligned and averaged, and a six averaged subtomograms were created. We calculated the *t* value for each voxel and present it as a single *t*-value map. The isosurface threshold values for the data sets were *t* \> 7.17, with a one-tailed probability of \<0.1%.

Measurement of swimming velocity
--------------------------------

The swimming velocity of *Chlamydomonas* cells was recorded using an inverted CK40 microscope (Olympus) at a total magnification of 100×. A red filter with a cutoff wavelength of 630 nm was inserted before the condenser lens to suppress the cellular response to light.
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